Emerging biotechs and their investors are exploring partnerships with drug companies at much earlier stages. Experts at ...

Policy pressure, affordability gaps, and consumer expectations are reshaping how pharma companies think about direct to patient access, according to Deepak Thomas and Sari Kaganoff.

On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination therapies for conditions as diverse as sleep apnea, ...

Firm consolidation, thoughtful staffing, disciplined scope control, and performance accountability can save life sciences ...

On this week's episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing technology that turned the mountains blue on cold Coors ...

Recently, the first patient in history was treated with an epigenetic editing therapy for facioscapulohumeral muscular dystrophy (FSHD). It was an extraordinary scientific milestone, but more ...

EmVenio is a global leader in clinical research, dedicated to advancing medical breakthroughs by making studies more accessible and inclusive. We believe that delivering meaningful results begins with ...

Neurological diseases now represent the leading cause of disability worldwide, with trial activity in this area growing rapidly — neurology studies increased 76% between 2015 and 2024 alone. Yet ...

On the Business of Biotech this week, Sahir Ali, Ph.D., founder and general partner at Modi Ventures, a family office investing at the intersection of technology and biology, talks about adapting the ...

The Sartocheck® 5 Plus perfectly meets today’s key industry requirements for filter integrity testing in demanding GMP environments. By combining a unique approach to Quality Risk Management, with ...

A conversation with Amanda Howley, Director of Services Solutions at Suvoda The World Medical Association (WMA) has announced a significant, rare update to its cornerstone ethical document, the ...

As the life sciences industry grapples with the demands of AI and the need to integrate real-world evidence into increasingly complex pipelines, the FAIR data principles — Findable, Accessible, ...